Truist Financial Maintains AnaptysBio(ANAB.US) With Hold Rating

Truist Financial analyst Joon Lee maintains $AnaptysBio(ANAB.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 22.4% over the pa

moomoo News02:31 ET

Truist Financial Sticks to Its Hold Rating for AnaptysBio (ANAB)

TipRanksMay 22 07:25 ET

Industry Analysts Just Made A Captivating Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts

AnaptysBio, Inc. (NASDAQ:ANAB) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's forecasts. The revenue forecast for this year has experien

Simply Wall StMay 22 06:37 ET

Express News | AnaptysBio Inc : JP Morgan Raises Target Price to $29 From $28

ReutersMay 14 23:40 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)

TipRanksMay 14 05:31 ET

AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

It's been a mediocre week for AnaptysBio, Inc. (NASDAQ:ANAB) shareholders, with the stock dropping 12% to US$23.41 in the week since its latest quarterly results. Revenues of US$7.2m crushed exp

Simply Wall StMay 11 10:07 ET